NCT01684319

Brief Summary

Various digestive manifestations are common in infants less than 6 months and have a significant impact on morbidity and quality of life of the family. In a prospective study on more than 2800 Italian infants followed by 0-6 months of life, it was determined that 55% of these children had gastrointestinal symptoms such as regurgitation (23%), colics (20%), constipation (17%) or poor weight gain (15%). However, these symptoms are not very accurate, and their cause is often difficult to determine. Frequently, the pediatrician will exclude cow's milk protein in infant feeding, but without a clear etiological diagnosis was asked. This measure causes significant additional costs through the use of extensively hydrolyzed milk specifically for children and involves an elimination diet of all foods containing cow's milk sometimes for several years. This can negatively influence the growth of the child. If the involvement of milk in these pathologies is suggested by some early studies (35% for colics, 68% in constipation, 42% in gastroesophageal reflux), it is unclear in the current state of knowledge if these gastrointestinal symptoms are actually due to an "allergy" to milk. Moreover, there is no validated diagnostic test for non-IgE-mediated gut allergy. However, various tests have proven their effectiveness in the investigation of non IgE-mediated allergy (eg. LAT, patch tests) and will be used in this study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2012

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2012

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

September 10, 2012

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 12, 2012

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2013

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2013

Completed
Last Updated

January 6, 2014

Status Verified

January 1, 2014

Enrollment Period

1 year

First QC Date

September 10, 2012

Last Update Submit

January 3, 2014

Conditions

Keywords

ConstipationGastroeosphageal refluxColics

Outcome Measures

Primary Outcomes (1)

  • Milk allergy in gastrointestinal diseases in young infants

    Establish the role of milk proteins in gastrointestinal diseases in young infants

    10 weeks

Secondary Outcomes (1)

  • Diagnostic tests

    10 weeks

Study Arms (2)

Infant formula milk

PLACEBO COMPARATOR

Infant formula milk adapted to age of infant

Dietary Supplement: Placebo

Formula milk free of milk proteins

ACTIVE COMPARATOR

Milk-free formula milk adapted to age of infant

Dietary Supplement: Formula milk free of cow's milk protein

Interventions

Formula milk free of milk proteins
PlaceboDIETARY_SUPPLEMENT

Infant formula milk

Infant formula milk

Eligibility Criteria

AgeUp to 6 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Infants 0-6 month old with at least one of the following symptoms : constipation, gastroesophageal reflux, colics

You may not qualify if:

  • Prematurity
  • exclusive breastfeeding
  • Other cause for symptoms

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Département de l'enfant et de l'adolesent - Hôpitaux Universitaires de Genève

Geneva, Canton of Geneva, 1211, Switzerland

Location

MeSH Terms

Conditions

ConstipationColic

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and SymptomsInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Philippe A Eigenmann, MD

    Hôpitaux Unversitaire de Genève

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
DIAGNOSTIC
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 10, 2012

First Posted

September 12, 2012

Study Start

August 1, 2012

Primary Completion

August 1, 2013

Study Completion

November 1, 2013

Last Updated

January 6, 2014

Record last verified: 2014-01

Locations